BioPharma Resources

Drug Trial Radar · NCT04663308

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 182 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

182

Actual

Start

Dec 18, 2020

Primary completion

Feb 20, 2026

Study completion Mar 2028

Sponsor

Lead sponsor
Mirum Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Dec 11, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

Conditions

  • Primary Sclerosing Cholangitis

Interventions

  • VolixibatDrug

    Oral capsules, administered twice daily. Volixibat is an Ileal Bile Acid Transporter (IBAT) inhibitor.

  • PlaceboDrug

    Capsules matched to study drug minus active substance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change in the daily itch scores using the Adult Itch Reported Outcome (Adult ItchRO) questionnaireTime frame: Baseline through to Week 28

Locations

103 sites in 14 countries. Site status is shown where the registry gives one.

  • Southern California Research Center

    Coronado, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • University of California, Davis

    Sacramento, California

  • California Pacific Medical Center Research Institute

    San Francisco, California

  • University of Colorado - Anschutz Medical Campus

    Aurora, Colorado

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Florida Research Institute

    Lakewood Rch, Florida

  • University of Miami - Schiff Center for Liver Diseases

    Miami, Florida

  • Tampa General Hospital

    Tampa, Florida

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Southern Therapy and Advanced Research LLC

    Jackson, Mississippi

  • Northwell Health

    Manhasset, New York

  • New York University Langone Health

    New York, New York

  • Weill Cornell Medical College

    New York, New York

  • Columbia University Medical Center - Presbyterian Hospital and Vanderbilt Clinic

    New York, New York

  • University of Rochester Medical Center - Strong Memorial Hospital

    Rochester, New York

  • Duke Health - Duke University Medical Center

    Durham, North Carolina

  • Science 37, Inc (Remote-homebased Telemedicine)

    Morrisville, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Einstein Healthcare Network - Einstein Medical Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Galen Medical Group

    Hixson, Tennessee

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • The Liver Institute At Methodist Dallas Medical Center

    Dallas, Texas

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • Houston Methodist Hospital

    Houston, Texas

  • Liver Associates of Texas

    Houston, Texas

  • University of Utah Health Care

    Salt Lake City, Utah

  • Bon Secours Liver Institution of Hampton Roads Mary Immaculate Hospital Office

    Newport News, Virginia

  • Richmond Community Hospital LLC

    Richmond, Virginia

  • University of Washington - Harborview Medical Center

    Seattle, Washington

  • Liver Institute Northwest

    Seattle, Washington

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina

  • Glenny Corp S.A.

    Ciudad Autónoma Buenos Aires, Argentina

  • Hospital El Cruce

    San Juan Bautista, Argentina

  • Royal Adelaide Hospital

    Adelaide, Australia

  • Northern Health

    Epping, Australia

  • Liverpool Hospital

    Liverpool, Australia

Showing 40 of 103 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.